证券代码：301515 证券简称：港通医疗 公告编号：2025-063 四川港通医疗设备集团股份有限公司 关于聘任公司副总经理的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 四川港通医疗设备集团股份有限公司（以下简称"公司"）第五届董事会第 七次会议于 2025 年 12 月 12 日召开，审议通过了《关于聘任公司副总经理的议 案》，同意聘任夏沧澜先生为公司副总经理，任期自第五届董事会第七次会议审 议通过之日起至第五届董事会任期届满之日止。根据《公司法》《公司章程》等 相关法律法规的有关规定，夏沧澜先生的提名已经公司董事会提名委员会审核通 过。 特此公告。 四川港通医疗设备集团股份有限公司董事会 2025 年 12 月 12 日 简历附件： 夏沧澜先生，中国国籍，无境外永久居留权，1981 年出生，博士研究生学 历，正高级经济师。曾任上海宏联工贸有限公司加贝分公司销售代表；中达电通 股份有限公司产品维修工程师、技术支持工程师、成都产品维修处经理；菲律宾 SCJohnson 客服代表、储备经理；成都华气厚普机电设备股份有限公司总经理助 理、人力资源总监、 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 四川港通医疗设备集团股份有限公司（以下简称"公司"）第五届董事会第 七次会议于 2025 年 12 月 12 日在公司会议室以现场结合通讯的方式召开。本次 会议通知于 2025 年 12 月 8 日以通讯方式发出，会议应出席董事 9 人，实际出席 董事 9 人（其中：刘煜强先生、魏勇先生、陈叙先生、姚刚先生、周正女士、赵 尘女士以通讯表决方式出席会议）。会议由董事长陈永先生召集并主持。本次会 议的召集、召开符合《公司法》和《公司章程》的有关规定，会议合法有效。 一、董事会会议审议情况 经过各位董事认真审议，本次会议形成如下决议： 证券代码：301515 证券简称：港通医疗 公告编号：2025-062 四川港通医疗设备集团股份有限公司 第五届董事会第七次会议决议公告 本议案已经公司董事会提名委员会审议通过。 具体内容详见公司同日在巨潮资讯网（www.cninfo.com.cn）披露的《关于 聘任公司副总经理的公告》（公告编号：2025-063）。 表决结果为：同意 9 票，反对 0 票，弃权 0 票。 二、备查文件 ...

Group 1 - The core viewpoint of the news is that 港通医疗 (Kangtong Medical) is experiencing a decline in stock performance and financial metrics, with a notable drop in revenue and net profit [1][2] - On December 10, 港通医疗's stock fell by 2.09%, with a trading volume of 19.84 million yuan, and a net financing purchase of 397,600 yuan [1] - The company's financing balance is 29.25 million yuan, accounting for 2.00% of its market capitalization, which is below the 10th percentile level over the past year, indicating a low financing level [1] Group 2 - As of November 28, the number of shareholders for 港通医疗 decreased by 5.24% to 7,481, while the average circulating shares per person increased by 5.53% to 8,426 shares [2] - For the period from January to September 2025, 港通医疗 reported a revenue of 344 million yuan, a year-on-year decrease of 30.06%, and a net profit attributable to shareholders of -10.21 million yuan, a decline of 150.92% [2] - 港通医疗 has distributed a total of 48.99 million yuan in dividends since its A-share listing [3]

Core Points - The Shenzhen-Hong Kong Stock Connect Medical Index (983036) closed at 4327.65 points, down 0.28%, with a trading volume of HKD 7.682 billion and a turnover rate of 0.9% [1] - Among the index constituents, 21 stocks rose while 36 stocks fell, with Kewei Medical leading the gainers at a 4.14% increase and Xianjian Technology leading the decliners at a 9.14% decrease [1] Index Constituents Summary - The top ten constituents of the Shenzhen-Hong Kong Stock Connect Medical Index include: - Mindray Medical (sz300760) with a weight of 14.56%, latest price at HKD 198.00, and a market cap of HKD 240.063 billion, down 0.36% [1] - Yier Eye Hospital (sz300015) with a weight of 11.62%, latest price at HKD 11.23, and a market cap of HKD 104.724 billion, down 0.62% [1] - Lejin Medical (sz300003) with a weight of 4.85%, latest price at HKD 15.64, and a market cap of HKD 28.831 billion, down 0.64% [1] - Aimeike (sz300896) with a weight of 4.80%, latest price at HKD 143.25, and a market cap of HKD 43.346 billion, up 1.47% [1] - Yuyue Medical (sz002223) with a weight of 4.66%, latest price at HKD 35.68, and a market cap of HKD 35.768 billion, up 0.17% [1] - Yingke Medical (sz300677) with a weight of 3.64%, latest price at HKD 41.76, and a market cap of HKD 27.360 billion, down 0.17% [1] - Furuijia (sz300049) with a weight of 3.59%, latest price at HKD 69.33, and a market cap of HKD 18.371 billion, down 0.82% [1] - Meinian Health (sz002044) with a weight of 3.58%, latest price at HKD 5.09, and a market cap of HKD 19.924 billion, up 0.39% [1] - Sinopharm Holdings (hk01099) with a weight of 3.35%, latest price at HKD 18.15, and a market cap of HKD 56.638 billion, down 0.40% [1] - Ping An Good Doctor (hk01833) with a weight of 2.63%, latest price at HKD 12.23, and a market cap of HKD 26.434 billion, down 3.24% [1] Capital Flow Analysis - The index constituents experienced a net outflow of HKD 382 million from institutional investors, while retail investors saw a net inflow of HKD 329 million [1] - Notable individual stock capital flows include: - Meinian Health (sz002044) with a net inflow of HKD 23.6308 million from institutional investors [2] - Aimeike (sz300896) with a net inflow of HKD 5.8353 million from institutional investors [2] - Yier Eye Hospital (sz300015) with a net outflow of HKD 20.7620 million from retail investors [2]

Core Viewpoint - The Shenzhen-Hong Kong Medical Index (983035) experienced a slight decline of 0.41%, closing at 4415.21 points on December 10, with a trading volume of 6.972 billion yuan and a turnover rate of 0.9% [1] Group 1: Index Performance - The Shenzhen-Hong Kong Medical Index closed at 4415.21 points, down 0.41% [1] - The index had a trading volume of 6.972 billion yuan and a turnover rate of 0.9% [1] - Among the constituent stocks, 21 companies saw an increase, with Kewei Medical leading at a 4.14% rise, while 36 companies declined, with Xianjian Technology leading the drop at 9.14% [1] Group 2: Capital Flow - The net outflow of main funds from the Shenzhen-Hong Kong Medical Index constituent stocks totaled 382 million yuan [2] - Retail investors contributed a net inflow of 329 million yuan, while speculative funds saw a net inflow of 53.373 million yuan [2] - Detailed capital flow information for the constituent stocks is available in the accompanying table [2]

资金流向方面，深港通医疗（983035）指数成份股当日主力资金净流出合计2.3亿元，游资资金净流入 合计3861.61万元，散户资金净流入合计1.91亿元。成份股资金流向详情见下表： 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 证券之星消息，12月9日，深港通医疗（983035）指数报收于4432.3点，跌1.49%，成交73.77亿元，换 手率0.99%。当日该指数成份股中，上涨的有7家，麦克奥迪以1.87%的涨幅领涨，下跌的有50家，先健 科技以8.38%的跌幅领跌。 深港通医疗（983035）指数十大成份股详情如下： ...

Group 1 - The core index of the Shenzhen-Hong Kong Stock Connect Medical Index closed at 4338.72 points, down 1.52% with a trading volume of 8.117 billion HKD and a turnover rate of 0.99% [1] - Among the constituent stocks, 7 companies experienced an increase, with Macao Di leading at a 1.87% rise, while 50 companies saw a decline, with Xianjian Technology leading the drop at 8.38% [1] Group 2 - The net outflow of main funds from the Shenzhen-Hong Kong Stock Connect Medical Index constituent stocks totaled 230 million HKD, while speculative funds saw a net inflow of 38.616 million HKD and retail investors had a net inflow of 191 million HKD [2]

Core Insights - The Shenzhen-Hong Kong Stock Connect Medical Index (983036) closed at 4406.89 points, down 0.24%, with a trading volume of HKD 7.939 billion and a turnover rate of 0.88% [1] - Among the index constituents, 23 stocks rose while 34 stocks fell, with Yiyang Sunshine leading the gainers at 3.98% and Jinxin Fertility leading the decliners at 3.89% [1] Index Constituents Summary - The top ten constituents of the Shenzhen-Hong Kong Stock Connect Medical Index are as follows: - Mindray Medical (sz300760) holds a weight of 14.56%, latest price at HKD 200.05, down 1.16%, with a market cap of HKD 242.549 billion [1] - Aier Eye Hospital (sz300015) has a weight of 11.62%, latest price at HKD 11.40, up 0.89%, with a market cap of HKD 106.31 billion [1] - Lepu Medical (sz300003) has a weight of 4.85%, latest price at HKD 15.89, up 0.38%, with a market cap of HKD 29.292 billion [1] - Aimeike (sz300896) has a weight of 4.80%, latest price at HKD 142.81, down 0.11%, with a market cap of HKD 43.213 billion [1] - Yuyue Medical (sz002223) has a weight of 4.66%, latest price at HKD 35.84, down 0.83%, with a market cap of HKD 35.929 billion [1] - Yingke Medical (sz300677) has a weight of 3.64%, latest price at HKD 43.72, up 0.97%, with a market cap of HKD 28.644 billion [1] - Furuide (sz300049) has a weight of 3.59%, latest price at HKD 70.75, up 0.71%, with a market cap of HKD 18.747 billion [1] - Meinian Onehealth (sz002044) has a weight of 3.58%, latest price at HKD 5.13, down 0.58%, with a market cap of HKD 20.08 billion [1] - Sinopharm (hk01099) has a weight of 3.35%, latest price at HKD 18.51, down 0.97%, with a market cap of HKD 57.767 billion [1] - Ping An Good Doctor (hk01833) has a weight of 2.63%, latest price at HKD 13.18, up 0.21%, with a market cap of HKD 28.495 billion [1] Capital Flow Analysis - The index constituents experienced a net outflow of main funds totaling HKD 230 million, while retail investors saw a net inflow of HKD 268 million [1] - Detailed capital flow for specific stocks shows: - Furuide (sz300049) had a main fund net inflow of HKD 8.7323 million, with retail outflows of HKD 3.3726 million [2] - Aier Eye Hospital (sz300015) had a main fund net inflow of HKD 6.6536 million, with retail outflows of HKD 1.8752 million [2] - Lepu Medical (sz300003) had a main fund net inflow of HKD 3.7716 million, with retail outflows of HKD 0.7273 million [2]

证券之星消息，12月5日，深港通医疗（983035）指数报收于4509.21点，涨0.83%，成交69.36亿元，换 手率0.85%。当日该指数成份股中，上涨的有39家，健康之路以7.52%的涨幅领涨，下跌的有16家，一脉 阳光以13.68%的跌幅领跌。 深港通医疗（983035）指数十大成份股详情如下： | 证券代码 | 股票简称 | 权重 | 最新价 | 涨跌幅 | 总市值(亿元) | | 所属行业 | | --- | --- | --- | --- | --- | --- | --- | --- | | sz300760 | 迈瑞医疗 | 14.56% | 202.39 | 1.20% | | 2453.86 | 医药生物 | | sz300015 | 爱尔眼科 | 11.62% | 11.30 | 0.62% | | 1053.77 | 医药生物 | | sz300003 | 乐普医疗 | 4.85% | 15.83 | 1.09% | | 291.81 | 医药生物 | | sz300896 | 爱美客 | 4.80% | 142.97 | 1.82% | 1 | 432.62 | 美容护理 | | ...

资金流向方面，深港通医疗(港币)（983036）指数成份股当日主力资金净流出合计2.24亿元，游资资金净 流出合计2064.25万元，散户资金净流入合计2.44亿元。成份股资金流向详情见下表： | 代码 | 名称 | 主力净流入(元) | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入(元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 300049 福瑞股份 | | 2710.53万 | 4.58% | -2326.67万 | -3.93% | -383.85万 | -0.65% | | 002044 | 美年健康 | 2672.84万 | 11.22% | -1892.21万 | -7.95% | -780.63万 | -3.28% | | 301267 | 华厦服科 | 1778.89万 | 15.22% | -247.70万 | -2.12% | -1531.19万 | -13.10% | | 000516 国际医学 | | - 97.68万 | 1.83% | 183.26万 | 3.44% | -28 ...